INVERO PHARMA

Invero Pharma is a partnership between Invero Health LLC and JMB Capital Partners Lending LLC. We are a late clinical-stage pharmaceutical and medical device company developing the proprietary use of xenon gas, delivered via a patented inhalation device, to protect against brain cell death following acute neurologic injury. Invero Pharma is currently preparing for a Phase III Clinical Trial in Out of Hospital Cardiac Arrest (OHCA) following a publication of positive Phase II Clinical Trial results in JAMA.¹... Invero Pharma, Inc. is a joint venture between Invero Health, LLC and JMB Capital Partners Lending, LLC

Also known as: Invero Health LLC, Invero Pharma, Inc.